VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Harvard Bioscience, Inc. (HBIO) Total Return Calculator with Dividends Reinvested

Harvard Bioscience, Inc.

Popular:

The total return for Harvard Bioscience, Inc. (HBIO) stock is +126.33% over the past 12 months. So far it's up 4.14% this year. The 5-year total return is -90.75%, meaning $10,000 invested in HBIO stock 5 years ago would be worth $925 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in HBIO 1 year ago, it would be worth $22,633 today — you'd have gained $12,633.

With Dividends Reinvested$22,633+126.33%

Price Only (No DRIP)$22,633+126.33%

Period2025-05-07 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in HBIO

1Y$22,633+$12,633 (+126.3%)126.3% CAGR

3Y$1,147-$8,853 (-88.5%)-51.4% CAGR

5Y$925-$9,075 (-90.7%)-37.9% CAGR

10Y$2,382-$7,618 (-76.2%)-13.4% CAGR

15Y$1,672-$8,328 (-83.3%)-11.2% CAGR

20Y$1,974-$8,026 (-80.3%)-7.8% CAGR

30Y$847-$9,153 (-91.5%)-7.9% CAGR

Harvard Bioscience, Inc. did not pay dividends during this period. Total return = price return.

Loading HBIO total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+4.14%	—	+4.14%	—	$10,414
1Y	+126.33%	126.33%	+126.33%	—	$22,633
3Y	-88.53%	-51.41%	-88.53%	—	$1,147
5Y	-90.75%	-37.88%	-90.75%	—	$925
10Y	-76.18%	-13.36%	-76.18%	—	$2,382
15Y	-83.28%	-11.24%	-83.28%	—	$1,672
20Y	-80.26%	-7.79%	-80.26%	—	$1,974
30Y	-91.53%	-7.90%	-91.53%	—	$847

Risk & Highlights

Best Year+174.19%2003

Worst Year-67.00%2025

Max Drawdown-92.47%2025-12-17 → 2026-01-24

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-5.58%	-5.58%	—	+0.41%	-6.0pp
2025	-67.00%	-67.00%	—	+16.64%	-83.6pp
2024	-60.85%	-60.85%	—	+24.00%	-84.9pp
2023	+99.63%	+99.63%	—	+24.81%	+74.8pp
2022	-61.20%	-61.20%	—	-19.95%	-41.3pp

HBIO outperformed the S&P 500 by 95.96pp over the past year (+126.33% vs +30.37%).

Loading summary...

HBIO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
HBIOHarvard Bioscience, Inc.	$304M	+25.7%	+4.1%	+126.3%	—	-88.5%	-90.7%	-76.2%
ITRNIturan Location and Control Ltd.	$1.4B	+14.5%	+42.2%	+76.7%	+8.6pp	+206.4%	+180.2%	+233.6%
BEATHeartBeam, Inc.	$35M	-25.6%	-64.2%	-53.7%	—	-59.1%	-81.4%	-81.4%
MLABMesa Laboratories, Inc.	$586M	+12.7%	+33.8%	-11.2%	+0.5pp	-33.0%	-56.5%	+4.5%
XPERXperi Inc.	$884M	+32.8%	+34.1%	+11.4%	—	-20.3%	-61.5%	-15.7%
LMATLeMaitre Vascular, Inc.	$2.5B	-2.2%	+34.9%	+33.3%	+1.0pp	+65.2%	+118.2%	+608.6%
WATWaters Corporation	$22.8B	+14.0%	-8.3%	+1.4%	—	+18.1%	+11.3%	+162.0%
TECHBio-Techne Corporation	$8.0B	-5.4%	-14.5%	+5.1%	+0.7pp	-37.0%	-50.3%	+112.5%
BRKRBruker Corporation	$6.7B	+19.3%	-9.0%	+7.8%	+0.5pp	-42.5%	-35.5%	+67.1%
CRLCharles River Laboratories International, Inc.	$9.0B	+7.3%	-10.1%	+32.8%	—	-4.2%	-46.9%	+119.2%
TMOThermo Fisher Scientific Inc.	$176.4B	-3.1%	-19.8%	+16.8%	+0.4pp	-11.7%	+2.8%	+229.1%

Compare:HBIO vs ITRN HBIO vs BEAT HBIO vs MLAB HBIO vs ITRN vs BEAT

About HBIO Dividend Returns

Harvard Bioscience, Inc. (HBIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of HBIO over the past year?

Harvard Bioscience, Inc. (HBIO) delivered a return of 126.33% over the past year. Since HBIO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in HBIO be worth today?

A $10,000 investment in Harvard Bioscience, Inc. one year ago would be worth $22,633 today, representing a gain of $12,633.

Q3Does HBIO pay dividends?

Harvard Bioscience, Inc. (HBIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For HBIO, the total return equals the price-only return.

Q4Did HBIO beat the S&P 500?

Yes, Harvard Bioscience, Inc. (HBIO) outperformed the S&P 500 by 95.96 percentage points over the past year. HBIO delivered a total return of 126.33%, compared to the S&P 500's 30.37%. This 95.96pp alpha means investors in HBIO earned more than a passive S&P 500 index fund.

Q5What is HBIO's worst drawdown?

Harvard Bioscience, Inc. (HBIO) experienced a maximum drawdown of -92.47% over the past year, declining from its peak on 2025-12-17 to its trough on 2026-01-24. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is HBIO's long-term total return over 10, 20, or 30 years?

Here are Harvard Bioscience, Inc. (HBIO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -76.2% (-13.4% CAGR) — $10,000 would have grown to $2,382. Over 20 years: -80.3% total return (-7.8% CAGR) — $10,000 → $1,974. Over 30 years: -91.5% total return (-7.9% CAGR) — $10,000 → $847. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was HBIO's best and worst year?

Harvard Bioscience, Inc.'s best calendar year was 2003 with a total return of 174.2%. Its worst year was 2025 with a total return of -67.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 241.2 percentage points.